Dihydroergotamine Mesylate Injection
»Dihydroergotamine Mesylate Injection is a sterile solution of Dihydroergotamine Mesylate in Water for Injection.It contains not less than 90.0percent and not more than 110.0percent of the labeled amount of C33H37N5O5·CH4O3S.
Packaging and storage— Preserve in single-dose containers,preferably of Type Iglass,protected from light.
Identification— Dilute 2mLof Injection with water to 25mL:the UVabsorption spectrum of the solution so obtained exhibits maxima and minima at the same wavelengths as that of a similar solution of USP Dihydroergotamine Mesylate RS,concomitantly measured.
Bacterial endotoxins á85ñ It contains not more than 175.0USP Endotoxin Units per mg of dihydroergotamine mesylate.
pHá791ñ: between 3.4and 4.9.
Other requirements— It meets the requirements under Injections á1ñ.
Assay—
Reagent preparation— Dissolve 250mg of p-dimethylaminobenzaldehyde in a cooled mixture of 130mLof sulfuric acid and 70mLof water,and add 0.40mLof ferric chloride solution (1in 20).
Standard preparation— Dissolve in tartaric acid solution (1in 100)a suitable quantity of USP Dihydroergotamine Mesylate RS,accurately weighed,and dilute quantitatively and stepwise with the same solvent to obtain a solution having a known concentration of about 50µg per mL.
Assay preparation— Transfer an accurately measured volume of Injection,equivalent to about 5mg of dihydroergotamine mesylate,to a 100-mLvolumetric flask,dilute with tartaric acid solution (1in 100)to volume,and mix.
Procedure— Transfer 5.0mLeach of the Standard preparation,the Assay preparation,and tartaric acid solution (1in 100)to provide the blank,to separate 50-mLconical flasks.Add 10.0mLof the Reagent preparationto each,shake,and allow to stand for 30minutes.Concomitantly determine the absorbances of the solutions in 1-cm cells at the wavelength of maximum absorbance at about 585nm,with a suitable spectrophotometer,using the blank to set the instrument.Calculate the quantity,in mg,of C33H37N5O5·CH4O3Sin each mLof the Injection taken by the formula:
(0.1C/V)(AU/AS),
in which Cis the concentration,in µg per mL,of USP Dihydroergotamine Mesylate RSin the Standard preparation,Vis the volume,in mL,of Injection taken,and AUand ASare the absorbances of the solutions from the Assay preparationand the Standard preparation,respectively.
Auxiliary Information— Staff Liaison:Ravi Ravichandran,Ph.D.,Senior Scientist
Expert Committee:(PA3)Pharmaceutical Analysis 3
USP28–NF23Page 648
Phone Number:1-301-816-8330